Straits Times Index
3,084.08 -6.23 (-0.20%) S&P 500
4,560.28 -34.35 (-0.75%) Dow
36,162.27 -83.23 (-0.23%) Nasdaq
14,141.15 -163.88 (-1.15%) Bitcoin USD
41,928.02 +2,288.68 (+5.77%) CMC Crypto 200
861.08 +2.37 (+0.28%)
Vir Biotechnology, Inc. (VIR)
| Previous close | 9.69 |
| Open | 9.61 |
| Bid | 9.49 x 800 |
| Ask | 9.50 x 1000 |
| Day's range | 9.40 - 9.89 |
| 52-week range | 7.72 - 31.55 |
| Volume | |
| Avg. volume | 1,462,857 |
| Market cap | 1.276B |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2023 Earnings Call Transcript
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2023 Earnings Call Transcript November 2, 2023 Vir Biotechnology, Inc. misses on earnings expectations. Reported EPS is $-1.22 EPS, expectations were $-1.21. Operator: Hello, and welcome to Vir Biotechnology’s Third Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded. At this time, […]
- Thomson Reuters StreetEvents
Q3 2023 Vir Biotechnology Inc Earnings Call
Q3 2023 Vir Biotechnology Inc Earnings Call
- Motley Fool
Is Vir Biotechnology Stock a Buy?
Early in the coronavirus pandemic, Vir Biotechnology's (NASDAQ: VIR) stock rose -- literally and figuratively -- as it joined the list of biotechs looking for vaccines and therapies for the disease. Vir's shares are down by 47% this year alone. This could be a buying opportunity for long-term investors, but only if Vir has enough growth fuel left in the tank.
